Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
5.09M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
320K
-
Shares change
-
-49.3K
-
Total reported value, excl. options
-
$166K
-
Value change
-
-$25.6K
-
Number of buys
-
11
-
Number of sells
-
-4
-
Price
-
$0.52
Significant Holders of Matinas BioPharma Holdings, Inc. - Common Stock, par value $0.0001 per share (MTNB) as of Q1 2025
24 filings reported holding MTNB - Matinas BioPharma Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Matinas BioPharma Holdings, Inc. - Common Stock, par value $0.0001 per share (MTNB) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 320K shares
of 5.09M outstanding shares and own 6.29% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (59.7K shares), BlackRock, Inc. (49.7K shares), GEODE CAPITAL MANAGEMENT, LLC (46.7K shares), Sargent Investment Group, LLC (41.8K shares), Holos Integrated Wealth LLC (32.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (25.6K shares), RENAISSANCE TECHNOLOGIES LLC (22.4K shares), TWO SIGMA SECURITIES, LLC (21K shares), STATE STREET CORP (15.3K shares), and UBS Group AG (1.64K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.